YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$12.37 USD
-0.44 (-3.43%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $12.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | -25.00% |
ABR | 1.67 |
Earnings ESP
|
-66.04% |
---|---|
Current Year | -0.52 |
Next Year | -0.47 |
EPS (TTM) | -0.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.09M | 24.93M | 95.22M | 112.25M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 23.90M | 25.30M | 97.46M | 118.43M |
Low Estimate | 22.00M | 24.30M | 92.60M | 104.70M |
Year ago Sales | 20.75M | 20.45M | 84.82M | 95.22M |
Year over Year Growth Est. | 11.28% | 21.88% | 12.26% | 17.88% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.13 | -0.52 | -0.47 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.11 | -0.08 | -0.40 | -0.22 |
High Estimate | -0.06 | -0.08 | -0.38 | -0.15 |
Low Estimate | -0.22 | -0.22 | -0.81 | -0.97 |
Year ago EPS | -0.14 | -0.18 | -0.49 | -0.52 |
Year over Year Growth Est. | 7.14% | 27.78% | -6.12% | 8.46% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.13 | -0.52 | -0.47 |
7 Days Ago | -0.13 | -0.13 | -0.52 | -0.47 |
30 Days Ago | -0.10 | -0.10 | -0.45 | -0.35 |
60 Days Ago | -0.10 | -0.10 | -0.45 | -0.35 |
90 Days Ago | -0.10 | -0.10 | -0.43 | -0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.22 | -0.81 | -0.97 |
Zacks Consensus Estimate | -0.13 | -0.13 | -0.52 | -0.47 |
Earnings ESP | -66.04% | -66.04% | -56.37% | -104.64% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.02 | -0.18 | -0.14 | NA |
Estimate | -0.12 | -0.19 | -0.16 | -0.24 | NA |
Difference | -0.03 | 0.17 | -0.02 | 0.10 | 0.06 |
Surprise | -25.00% | 89.47% | -12.50% | 41.67% | 23.41% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more